Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 15 studies | 23% ± 7% | |
| glutamatergic neuron | 12 studies | 53% ± 23% | |
| GABAergic neuron | 9 studies | 43% ± 25% | |
| adipocyte | 7 studies | 27% ± 6% | |
| neuron | 6 studies | 30% ± 11% | |
| cardiac muscle cell | 6 studies | 43% ± 13% | |
| ciliated cell | 6 studies | 23% ± 6% | |
| pericyte | 6 studies | 21% ± 4% | |
| endothelial cell | 4 studies | 33% ± 12% | |
| interneuron | 4 studies | 49% ± 19% | |
| GABAergic interneuron | 3 studies | 29% ± 8% | |
| oligodendrocyte precursor cell | 3 studies | 20% ± 6% | |
| retinal ganglion cell | 3 studies | 39% ± 19% | |
| epithelial cell | 3 studies | 19% ± 3% | |
| muscle cell | 3 studies | 52% ± 21% | |
| astrocyte | 3 studies | 34% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 89% | 5210.46 | 2342 / 2642 | 94% | 41.11 | 666 / 705 |
| uterus | 91% | 2126.97 | 155 / 170 | 66% | 19.15 | 305 / 459 |
| prostate | 65% | 1349.14 | 160 / 245 | 92% | 18.59 | 460 / 502 |
| breast | 57% | 872.07 | 260 / 459 | 96% | 38.95 | 1073 / 1118 |
| adrenal gland | 80% | 1249.50 | 206 / 258 | 71% | 12.30 | 164 / 230 |
| bladder | 86% | 2008.76 | 18 / 21 | 51% | 6.75 | 258 / 504 |
| esophagus | 63% | 2297.62 | 908 / 1445 | 69% | 9.59 | 126 / 183 |
| thymus | 44% | 554.55 | 290 / 653 | 78% | 9.57 | 473 / 605 |
| ovary | 18% | 280.47 | 33 / 180 | 97% | 18.80 | 418 / 430 |
| kidney | 22% | 271.30 | 20 / 89 | 91% | 21.87 | 824 / 901 |
| intestine | 69% | 2824.01 | 668 / 966 | 37% | 3.75 | 197 / 527 |
| muscle | 100% | 32266.54 | 803 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 5059.39 | 1323 / 1335 | 0% | 0 | 0 / 0 |
| liver | 2% | 23.25 | 5 / 226 | 91% | 27.16 | 371 / 406 |
| heart | 89% | 4141.31 | 765 / 861 | 0% | 0 | 0 / 0 |
| lung | 15% | 168.84 | 86 / 578 | 68% | 9.05 | 786 / 1155 |
| stomach | 34% | 1212.09 | 123 / 359 | 48% | 7.22 | 136 / 286 |
| eye | 0% | 0 | 0 / 0 | 79% | 12.73 | 63 / 80 |
| skin | 5% | 65.26 | 83 / 1809 | 71% | 23.40 | 337 / 472 |
| pancreas | 2% | 18.57 | 6 / 328 | 72% | 7.70 | 128 / 178 |
| adipose | 56% | 882.52 | 680 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 36% | 3.84 | 16 / 45 |
| spleen | 1% | 8.98 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.80 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0007015 | Biological process | actin filament organization |
| GO_0007163 | Biological process | establishment or maintenance of cell polarity |
| GO_0007190 | Biological process | activation of adenylate cyclase activity |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0019933 | Biological process | cAMP-mediated signaling |
| GO_0099140 | Biological process | presynaptic actin cytoskeleton organization |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008179 | Molecular function | adenylate cyclase binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | CAP2 |
| Protein name | Cyclase associated actin cytoskeleton regulatory protein 2 Adenylyl cyclase-associated protein 2 (CAP 2) Adenylyl cyclase-associated protein |
| Synonyms | |
| Description | FUNCTION: May have a regulatory bifunctional role. |
| Accessions | E9PDI2 F8WEW0 ENST00000229922.7 [P40123-1] ENST00000465994.5 [P40123-2] ENST00000476263.1 P40123 ENST00000493172.5 [P40123-3] ENST00000479291.5 ENST00000489374.5 B7Z385 ENST00000378990.6 F8WDB9 |